Elite Pharmaceuticals (OTCMKTS:ELTP) Shares Pass Below 200 Day Moving Average – Should You Sell?

Elite Pharmaceuticals Inc. (OTCMKTS:ELTP)’s stock price passed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $0.41 and traded as low as $0.35. Elite Pharmaceuticals shares last traded at $0.3690, with a volume of 352,594 shares.

Elite Pharmaceuticals Stock Up 0.0%

The company has a market capitalization of $397.46 million, a price-to-earnings ratio of 12.30 and a beta of 0.38. The stock’s fifty day simple moving average is $0.36 and its two-hundred day simple moving average is $0.41. The company has a debt-to-equity ratio of 0.05, a current ratio of 7.34 and a quick ratio of 5.44.

Elite Pharmaceuticals Company Profile

Elite Pharmaceuticals, Inc is a U.S.-based specialty pharmaceutical company that acquires, develops and markets both branded and generic pharmaceutical products. Headquartered in Houston, Texas, the company focuses on complex dosage forms—including injectables, sterile formulations and oncology therapies—and seeks to address unmet medical needs through advanced drug delivery technologies. Its product portfolio spans therapeutic areas such as pain management, oncology and cardiovascular care.

Since its founding in 2007, Elite Pharmaceuticals has pursued strategic partnerships and licensing agreements to expand its pipeline and manufacturing capabilities.